<--- Back to Details
First PageDocument Content
Syntex / Analytical chemistry / Topical decongestants / Phenylephrine / Volumetric flask / High-performance liquid chromatography / Calibration curve / Acetonitrile / Chemistry / Non-steroidal anti-inflammatory drugs / Ketorolac
Date: 2015-04-30 14:39:03
Syntex
Analytical chemistry
Topical decongestants
Phenylephrine
Volumetric flask
High-performance liquid chromatography
Calibration curve
Acetonitrile
Chemistry
Non-steroidal anti-inflammatory drugs
Ketorolac

International Journal of Chemical and Natural Science

Add to Reading List

Source URL: ijcns.aizeonpublishers.net

Download Document from Source Website

File Size: 1,22 MB

Share Document on Facebook

Similar Documents

In D. Reitter & F. E. Ritter (Eds.), Proceedings of the 14th International Conference on Cognitive Modeling (ICCMUniversity Park, PA: Penn State. Effects of Guanfacine and Phenylephrine on a Spiking Neuron Model

DocID: 1uIFb - View Document

PROGRAMME DE SURVEILLANCE* 2016 Les substances ci-dessous sont incluses dans le programme de surveillance 2016 : 1. Stimulants : En compétition seulement : Bupropion, caféine, nicotine, phényléphrine, phénylpropanol

DocID: 1qrJn - View Document

Decongestants / Alcohols / Methamphetamine / Pseudoephedrine / Phenylephrine / Hydrogen peroxide / Phenylpropanolamine / Over-the-counter drug / Topical decongestant / Ephedrine / Peroxide / American Association of Poison Control Centers

Official Newsletter of the Utah Poison Control Center 2008 • Volume 10 • Issue 1 The University of Utah Utah Poison Control Center

DocID: 1oyfz - View Document

THE 2016 MONITORING PROGRAM* The following substances are placed on the 2016 Monitoring Program: 1. Stimulants: In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol and syneph

DocID: 1nNeY - View Document

THE 2016 MONITORING PROGRAM* The following substances are placed on the 2016 Monitoring Program: 1. Stimulants: In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol and syneph

DocID: 1ne21 - View Document